• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project.识别慢性肾脏病高危人群:CHERISH 社区示范项目的结果。
Am J Nephrol. 2018;48(6):447-455. doi: 10.1159/000495082. Epub 2018 Nov 23.
2
The See Kidney Disease Targeted Screening Program for CKD.慢性肾脏病(CKD)的SEE肾脏疾病靶向筛查项目
Clin J Am Soc Nephrol. 2016 Jun 6;11(6):964-972. doi: 10.2215/CJN.11961115. Epub 2016 May 19.
3
Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study.危地马拉农村社区糖尿病队列中慢性肾脏病的筛查:一项横断面研究。
BMJ Open. 2018 Jan 21;8(1):e019778. doi: 10.1136/bmjopen-2017-019778.
4
Diagnostic Yield of Population-Based Screening for Chronic Kidney Disease in Low-Income, Middle-Income, and High-Income Countries.基于人群的慢性肾脏病筛查在低收入、中等收入和高收入国家的诊断收益。
JAMA Netw Open. 2021 Oct 1;4(10):e2127396. doi: 10.1001/jamanetworkopen.2021.27396.
5
Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review.社区环境下靶向筛查慢性肾脏病的效果:系统评价。
J Nephrol. 2018 Feb;31(1):27-36. doi: 10.1007/s40620-017-0375-0. Epub 2017 Feb 8.
6
The National Kidney Foundation of Illinois KidneyMobile: a mobile resource for community based screenings of chronic kidney disease and its risk factors.伊利诺伊州肾脏基金会的 KidneyMobile:一个移动资源,用于在社区进行慢性肾脏病及其危险因素的筛查。
BMC Nephrol. 2018 Oct 25;19(1):295. doi: 10.1186/s12882-018-1079-y.
7
Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US.墨西哥肾脏早期评估项目(KEEP)中慢性肾脏病的患病率及与美国KEEP的比较。
Kidney Int Suppl. 2010 Mar(116):S2-8. doi: 10.1038/ki.2009.540.
8
Diabetes mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004.慢性肾脏病中的糖尿病:肾脏早期评估项目(KEEP)及1999 - 2004年国家健康与营养检查调查(NHANES)
Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S21-9. doi: 10.1053/j.ajkd.2007.12.013.
9
The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.使用慢性肾脏病风险评分筛查早期慢性肾脏病的成本效益
BMC Nephrol. 2017 Mar 13;18(1):85. doi: 10.1186/s12882-017-0497-6.
10
Screening for chronic kidney disease in Australia: a pilot study in the community and workplace.澳大利亚慢性肾病筛查:社区与工作场所的一项试点研究
Kidney Int Suppl. 2010 Mar(116):S9-16. doi: 10.1038/ki.2009.538.

引用本文的文献

1
Utility of a novel point-of-care test for albuminuria in communities at high risk for chronic kidney disease in Thailand.泰国慢性肾脏病高危社区中一种新型即时检验蛋白尿方法的效用
BMJ Public Health. 2025 Jan 16;3(1):e001412. doi: 10.1136/bmjph-2024-001412. eCollection 2025 Jan.
2
Caregiver burden and quality of life among family caregivers of hemodialysis patients from South India.印度南部血液透析患者家庭照顾者的照顾负担与生活质量
J Educ Health Promot. 2024 Dec 28;13:486. doi: 10.4103/jehp.jehp_273_24. eCollection 2024.
3
Prevalence of undetected chronic kidney disease in high-risk middle-aged patients in primary care: a cross-sectional study.基层医疗中高危中年患者未被检测出的慢性肾脏病患病率:一项横断面研究
Front Med (Lausanne). 2024 Aug 13;11:1412689. doi: 10.3389/fmed.2024.1412689. eCollection 2024.
4
Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?筛查、识别和治疗慢性肾脏病:为何、何人、何时、如何以及筛查什么?
BMC Nephrol. 2024 Jan 25;25(1):34. doi: 10.1186/s12882-024-03466-5.
5
Computational Analysis Reveals Distinctive Interaction of miRNAs with Target Genes in the Pathogenesis of Chronic Kidney Disease.计算分析揭示 miRNA 在慢性肾脏病发病机制中与靶基因的独特相互作用。
Genes (Basel). 2023 Apr 12;14(4):898. doi: 10.3390/genes14040898.
6
Lifestyle changes and kidney function: A 10-year follow-up study in patients with manifest cardiovascular disease.生活方式改变与肾功能:有明显心血管疾病患者的 10 年随访研究。
Eur J Clin Invest. 2022 Sep;52(9):e13814. doi: 10.1111/eci.13814. Epub 2022 May 27.
7
Scoring model to predict risk of chronic kidney disease in Chinese health screening examinees with type 2 diabetes.用于预测中国健康体检 2 型糖尿病患者发生慢性肾脏病风险的评分模型。
Int Urol Nephrol. 2022 Jul;54(7):1629-1639. doi: 10.1007/s11255-021-03045-9. Epub 2021 Nov 1.
8
End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study.患有临床表现性血管疾病患者的终末期肾病;发病率及危险因素:UCC-SMART队列研究结果
J Nephrol. 2021 Oct;34(5):1511-1520. doi: 10.1007/s40620-021-00996-1. Epub 2021 Mar 13.
9
Community Screening for Diabetes, Hypertension, Nutrition, and Kidney Disease Among Kenyans.肯尼亚人群中糖尿病、高血压、营养状况及肾脏疾病的社区筛查
Kidney Int Rep. 2019 Jul 5;4(10):1482-1484. doi: 10.1016/j.ekir.2019.06.015. eCollection 2019 Oct.
10
Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease.收缩压和舒张压变异性与终末期肾病风险的关系。
Hypertension. 2019 Oct;74(4):880-887. doi: 10.1161/HYPERTENSIONAHA.119.13422. Epub 2019 Aug 19.

本文引用的文献

1
10. Microvascular Complications and Foot Care: .10. 微血管并发症与足部护理:
Diabetes Care. 2018 Jan;41(Suppl 1):S105-S118. doi: 10.2337/dc18-S010.
2
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师协会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药剂师协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Hypertension. 2018 Jun;71(6):e13-e115. doi: 10.1161/HYP.0000000000000065. Epub 2017 Nov 13.
3
Metformin Use in Prediabetes Among U.S. Adults, 2005-2012.2005 - 2012年美国成年人糖尿病前期患者中二甲双胍的使用情况
Diabetes Care. 2017 Jul;40(7):887-893. doi: 10.2337/dc16-1509. Epub 2017 Apr 3.
4
Trends in Prevalence of Chronic Kidney Disease in the United States.美国慢性肾脏病患病率的趋势
Ann Intern Med. 2016 Oct 4;165(7):473-481. doi: 10.7326/M16-0273. Epub 2016 Aug 2.
5
Need for chronic kidney disease prevention programs in disadvantaged populations.弱势群体中慢性肾脏病预防项目的必要性。
Clin Nephrol. 2015;83(7 Suppl 1):42-8. doi: 10.5414/cnp83s042.
6
Epidemiological study of chronic kidney disease progression: a large-scale population-based cohort study.慢性肾脏病进展的流行病学研究:一项基于大规模人群的队列研究。
Medicine (Baltimore). 2015 Jan;94(4):e475. doi: 10.1097/MD.0000000000000475.
7
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.KDIGO 美国评论:2012 年 KDIGO 慢性肾脏病评估与管理临床实践指南
Am J Kidney Dis. 2014 May;63(5):713-35. doi: 10.1053/j.ajkd.2014.01.416. Epub 2014 Mar 16.
8
Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement.慢性肾脏病筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Oct 16;157(8):567-70. doi: 10.7326/0003-4819-157-8-201210160-00533.
9
Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction.慢性肾脏病在有肾功能障碍临床标志物的个体中的认知情况。
Clin J Am Soc Nephrol. 2011 Aug;6(8):1838-44. doi: 10.2215/CJN.00730111. Epub 2011 Jul 22.
10
Intensive blood-pressure control in hypertensive chronic kidney disease.高血压性慢性肾脏病的强化血压控制。
N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975.

识别慢性肾脏病高危人群:CHERISH 社区示范项目的结果。

Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project.

机构信息

Centers for Disease Control and Prevention, Division of Diabetes Translation, Atlanta, Georgia, USA,

National Kidney Foundation, Inc., New York, New York, USA.

出版信息

Am J Nephrol. 2018;48(6):447-455. doi: 10.1159/000495082. Epub 2018 Nov 23.

DOI:10.1159/000495082
PMID:30472707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6624836/
Abstract

BACKGROUND

Most people with chronic kidney disease (CKD) are not aware of their condition.

OBJECTIVES

To assess screening criteria in identifying a population with or at high risk for CKD and to determine their level of control of CKD risk factors.

METHOD

CKD Health Evaluation Risk Information Sharing (CHERISH), a demonstration project of the Centers for Disease Control and Prevention, hosted screenings at 2 community locations in each of 4 states. People with diabetes, hypertension, or aged ≥50 years were eligible to participate. In addition to CKD, screening included testing and measures of hemoglobin A1C, blood pressure, and lipids. -Results: In this targeted population, among 894 people screened, CKD prevalence was 34%. Of participants with diabetes, 61% had A1C < 7%; of those with hypertension, 23% had blood pressure < 130/80 mm Hg; and of those with high cholesterol, 22% had low-density lipoprotein < 100 mg/dL.

CONCLUSIONS

Using targeted selection criteria and simple clinical measures, CHERISH successfully identified a population with a high CKD prevalence and with poor control of CKD risk factors. CHERISH may prove helpful to state and local programs in implementing CKD detection programs in their communities.

摘要

背景

大多数慢性肾脏病(CKD)患者并未意识到自己的病情。

目的

评估用于识别存在或存在 CKD 风险人群的筛选标准,并确定其 CKD 风险因素控制水平。

方法

疾病预防控制中心的“CKD 健康评估风险信息共享(CHERISH)”项目在 4 个州的每个社区的 2 个地点进行了筛查。有糖尿病、高血压或年龄≥50 岁的人有资格参加。除 CKD 外,筛查还包括血红蛋白 A1C、血压和血脂检测和测量。 -结果:在这个目标人群中,在 894 名接受筛查的人中,CKD 患病率为 34%。在患有糖尿病的参与者中,61%的人 A1C<7%;在患有高血压的参与者中,23%的人血压<130/80mmHg;在高胆固醇血症患者中,22%的人低密度脂蛋白<100mg/dL。

结论

通过使用有针对性的选择标准和简单的临床指标,CHERISH 成功地识别了 CKD 患病率高且 CKD 风险因素控制不佳的人群。CHERISH 可能有助于州和地方计划在其社区实施 CKD 检测计划。